Grants for Schools & Universities
1,200 open opportunities. Open federal grants for colleges, universities, and other educational institutions, each with a plain-English eligibility summary, deadline, and award amount.
The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
Due Nov 22, 2028National Institutes of Health · Up to $500K
This NIH/NCI U01 cooperative agreement funds research projects within the Metastasis Research Network that use systems-level approaches to study cancer metastasis as a whole-body problem. Both U.S. and foreign organizations may apply, but applications including funded foreign subawards/subcontracts will be deemed noncompliant. The award ceiling is up to about $500,000.
ResearchersSchools & universitiesLarge awardBroad eligibilityAdministrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp Clinical Trial Optional)
Due Nov 30, 2028National Institutes of Health · Amount varies
This NIH opportunity provides administrative supplements only to organizations that already hold an active, eligible NIH grant or cooperative agreement, to cover unforeseen increased costs within the scope of the existing project. New applicants without a current NIH award cannot use it. Funding is not guaranteed, and applicants must discuss requests with the awarding Institute's staff before submitting; foreign organizations may apply only consistent with the existing parent award.
ResearchersSchools & universitiesNarrow eligibilityFOUNDATIONS OF TRUSTED SYSTEMS
Due Dec 5, 2028Air Force -- Research Lab · Up to $99.9M
This is an Air Force Research Lab research-and-development opportunity (Foundations of Trusted Systems) for organizations working in defense-related science and technology. The total ceiling across the program is very large (up to roughly $99.9M), so awards typically go to established research institutions, universities, and contractors rather than small applicants. Full eligibility and requirements are only in the linked SAM.gov notice, so review that posting before applying.
ResearchersSchools & universitiesLarge awardNarrow eligibilityLimited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
Due Jan 26, 2029National Institutes of Health · $25K–$250K
This NIH S10 instrumentation grant funds resource-limited institutions to purchase state-of-the-art scientific instruments supporting biomedical research and education. It is a limited competition that invites applications only from eligible organizations, and awards range from about $25,000 to $250,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersNarrow eligibilityBiomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Due Jan 29, 2029National Institutes of Health · Amount varies
This NIH/NIGMS RM1 grant funds Biomedical Technology Optimization and Dissemination Centers to refine late-stage research technologies and sustainably share them with the wider biomedical research community. Applicants should be leaders in their technology field and within the NIGMS mission. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityMaximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Due Feb 6, 2029National Institutes of Health · Amount varies
This NIH/NIGMS award (MIRA for Early Stage Investigators) funds early-career biomedical researchers at U.S. institutions to run an independent research program aligned with the NIGMS mission. It is aimed at Early Stage Investigators, so it is restrictive by career stage. Non-U.S. (foreign) institutions and foreign components of U.S. organizations are not eligible to apply, though foreign components within projects may be allowed per NIH policy.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Due Feb 9, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative R61/R33 grant funds action-oriented research that translates addiction epidemiology, prevention, treatment, and recovery findings into practice to address the opioid crisis and overdose. Projects can target individual, provider, organizational, community, or system levels. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityResearch Grants in Clinical Informatics (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · $0–$250K
This NIH/NLM R01 grant funds research teams developing and evaluating clinical informatics tools and methods that turn health data (such as electronic health records, clinical notes, and imaging) into actionable knowledge. Both U.S. and foreign organizations are eligible to apply, but applications involving funded foreign subawards/subcontracts will be rejected under NIH's post-May-2025 policy. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityAdvancing Bioinformatics, Translational Bioinformatics and Computational Biology Research (R01 Clinical Trial Optional)
Due Mar 5, 2029National Institutes of Health · Up to $250K
This NIH/NLM R01 grant supports research advancing bioinformatics, translational bioinformatics, and computational biology, including AI and machine-learning methods for interpreting large biological datasets. Both U.S. and foreign organizations may apply, but applications that include funded foreign subawards/subcontracts will be deemed noncompliant and not considered. The award ceiling is up to about $250,000.
ResearchersSchools & universitiesBroad eligibilityPaul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Due Mar 12, 2029National Institutes of Health · Amount varies
This NIH (K12) career development award supports institutions in training clinician-scientists for clinical and translational cancer research. It is an institutional mentored program; scholars may gain experience in a mentor-led clinical trial but may not lead an independent clinical trial. Only domestic U.S. organizations may apply, foreign organizations are not eligible, though foreign components are allowed. It primarily suits academic medical centers and research institutions building oncology research careers.
Schools & universitiesResearchersNarrow eligibilityMathematical Sciences Research Institutes
Due Mar 14, 2029U.S. National Science Foundation · $1.5M–$6.5M
This National Science Foundation program funds Mathematical Sciences Research Institutes as national resources that advance research in mathematics and statistics and broaden participation, with awards ranging roughly from $1.5 million to $6.5 million. Only U.S.-based non-profit non-academic research organizations and accredited institutions of higher education may apply; multi-institutional consortia are allowed but one entity must take overall management responsibility. Individuals and for-profit firms are not eligible.
Schools & universitiesNonprofitsResearchersLarge award+1 moreScience Track Award for Research Transition (START) Program (R03, Clinical Trial Optional)
Due Mar 16, 2029National Institutes of Health · Amount varies
This NIH (R03) award helps investigators enter high-priority substance use research, including HIV comorbidity, by funding the collection of preliminary data to support future larger grants and career advancement. Eligibility is comparatively open for NIH: foreign organizations and foreign components of U.S. organizations are both eligible to apply, and foreign components are allowed. It suits researchers and institutions transitioning into substance use research fields. No specific award amount is listed.
ResearchersSchools & universitiesARMY APPLICATIONS LAB BROAD AGENCY ANNOUNCEMENT FOR DISRUPTIVE APPLICATIONS
Due Apr 4, 2029Dept of the Army -- Materiel Command · Amount varies
The Army Applications Lab Broad Agency Announcement funds basic and applied scientific research in defense-relevant areas described in the BAA. Eligibility is unusually broad: institutions of higher education, nonprofits, state and local governments, foreign organizations and public entities, and for-profit businesses (large and small) may all apply. No specific award amount is listed, and projects are selected through full and open competition, so applicants should review the BAA's stated research areas of interest.
ResearchersSmall businessNonprofitsSchools & universities+2 morePredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityBiological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityNIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH award is open only to U.S. institutions located in IDeA-eligible states/jurisdictions (a fixed list including Alaska, Arkansas, Delaware, Hawaii, Kentucky, Mississippi and others) that grant doctoral degrees in health-related sciences or are NIH-funded biomedical research institutes. It funds the expansion and sustainability of existing Centers of Biomedical Research Excellence, building faculty, research projects, and core facilities. Eligibility is narrow: it is a limited competition by invitation, applicants may hold no more than three active COBRE awards, and foreign organizations and foreign components are not eligible.
Schools & universitiesResearchersNarrow eligibility